Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 333-337

  Lewensohn Fuchs, I ^a   Ljungman, P ^a   Kjerrstrom A ^a   Ringden O ^a   Dalianis, T ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BMT; HPV; Serology; Synthetic peptides

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SERODIAGNOSIS; SEROLOGY; WART VIRUS;

ADULT; AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; BONE MARROW TRANSPLANTATION; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029810704     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pfister H. Biology and biochemistry of papillomaviruses. Rev Physiol Biochem Pharmacol 1984; 99: 111-181.
2. Pfister H. Human papillomaviruses and genital cancer. Adv Cancer Res 1987; 48: 113-147.
3. Schneider V, Kay S, Lee H. Immunosuppression as a high risk factor in the development of condyloma accuminatum and squamous neoplasia of the cervix. Acta Cytologica 1983; 27: 3220-3224.
4. Socié G, Kolb J, Ljungman P. Malignant diseases after allogeneic bone marrow transplantation: the case for assessment of risk factors. Br J Haematol 1992; 80: 427-430.
5. Wahren B, Gahrton G, Linde A et al. Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. J Inf Dis 1984; 150: 358-365.
6. Ljungman P, Fridell E, Lönnqvist B et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps and rubella vaccine. J Inf Dis 1989; 159: 610-615.
7. Ljungman P, Lewensohn-Fuchs I, Hammarström V et al. Long-term immunity to measles, mumps and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657-663.
8. Pauksen K, Duraj V, Ljungman P et al. Immunity to and immunization against measles, rubella, and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427-432.
9. Ahmed R, Stevens JG. Viral persistence. In: Fields BN, Knipe DM (eds). Fields Virology. Raven Press: New York, 1990, pp 241-266.
10. Taichman LB, LaPorta RF. The expression of papillomaviruses in epithelial cells. In: Salzman NP, Howley PM (eds). The Papovaviruses. Plenum Press: New York, 1987, pp 109-139.
11. Meijer CJLM, van de Brule AJC, Snijders PFJ et al. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical screening. In: Munoz N, Bosch FX, Shah KV, Meheus A (eds). The Epidemiology of Human Papillomavirus and Cervical Cancer. IARC Scientific Publications: Lyon, France, 1992, pp 271-281.
12. Van Doornum GJ, Prins M, Pronk L et al. A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA. Clin Diag Lab Immunol 1994; 1: 633-639.
13. Kirnbauer R, Hubbert NL, Wheeler CM et al. A virus-like particle enzyme-linked immunosorbent assay detects antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 1994; 86: 494-499.
14. Wikström A, van Doornum GJ, Quint WG et al. Identification of human papillomavirus seroconversions. J Gen Virol 1995; 76: 529-539.
15. Heino P, Eklund C, Fredriksson-Shanazarian V et al. Association of serum immunoglobulin G antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J Natl Cancer Inst 1995; 87: 437-440.
16. Andersson-Ellström A, Dillner J, Hagmar B et al. No serological evidence for non-sexual spread of HPV 16. Lancet 1994; 344: 1435.
17. Wikström A, Eklund C, von Krogh G et al. Levels of immunoglobulin G antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condyloma acuminata. J Clin Microbiol 1992; 30: 1795-1800.
18. Ringdén O, Pihlstedt P, Markling L et al. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221-226.
19. Dillner J, Dillner L, Utter G et al. Mapping of linear epitopes of human papilloma virus type 16: the L1 and L2 open reading frames. Int J Cancer 1990; 45: 529-535.
20. Wimperis J, Brenner M, Prentice HG et al. Transfer of a functioning humoral immune system in transplantation of T lymphocyte-depleted bone marrow. Lancet 1986; 1: 339-343.
21. Ljungman P, Gahrton G, Ringden O, Wahren B. Donor and recipient origin of herpes virus-reactive lymphocytes after bone marrow transplantation. Brief report. Arch Virol 1985; 83: 117-122.
22. Ljungman P, Lönnqvist B, Gahrton G et al. Clinical and subclinical reactivations of varicellae zoster virus in immunocompromised patients. J Inf Dis 1986; 153: 840-844.
23. Ljungman P, Duraj V, Magnius L. Responses to immunisation against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89-93.
24. Lewensohn-Fuchs I, Berke Z, Elfgren K, Dalianis T. Human papillomavirus (DNA) is not detected in the peripheral blood cells (PBL) of patients with cervical carcinoma. Genitourinary Med 1994; 70: 359-360.